M&T Bank’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-113,882
Closed -$473K – 1629
2024
Q4
$473K Buy
113,882
+104
+0.1% +$393 ﹤0.01% 1192
2024
Q3
$443K Buy
113,778
+25,644
+29% +$108K ﹤0.01% 1204
2024
Q2
$345K Buy
88,134
+80
+0.1% +$344 ﹤0.01% 1252
2024
Q1
$369K Buy
88,054
+182
+0.2% +$854 ﹤0.01% 1246
2023
Q4
$413K Sell
87,872
-75,641
-46% -$295K ﹤0.01% 1190
2023
Q3
$510K Buy
163,513
+5,443
+3% +$21.9K ﹤0.01% 1075
2023
Q2
$726K Buy
158,070
+33,132
+27% +$152K ﹤0.01% 986
2023
Q1
$618K Hold
124,938
– – ﹤0.01% 1043
2022
Q4
$682K Buy
124,938
+19,312
+18% +$118K ﹤0.01% 992
2022
Q3
$686K Hold
105,626
– – ﹤0.01% 960
2022
Q2
$500K Buy
+105,626
New +$520K ﹤0.01% 1006
2022
Q1
– Sell
-24,742
Closed -$252K – 1613
2021
Q4
$252K Buy
24,742
+1,350
+6% +$14.5K ﹤0.01% 1335
2021
Q3
$286K Buy
+23,392
New +$353K ﹤0.01% 1259

Other funds holding MXCT

M&T Bank's MXCT Position: Q1 2025 in Review

M&T Bank sold out of MaxCyte (MXCT) in Q1 2025, closing a stake of 113,882 shares — an estimated $473K sold.

M&T Bank first reported a position in MXCT in Q3 2021 and held it in 13 quarters. The position peaked at $726K in Q2 2023. 115 funds tracked by Wall St. Rank hold MXCT as of Q1 2025.

  • M&T Bank reported no remaining MaxCyte position as of Q1 2025 after selling out during the quarter.
  • M&T Bank sold 113,882 MaxCyte shares in Q1 2025, an estimated $473K.
  • M&T Bank first reported a position in MaxCyte in Q3 2021 and held it in 13 quarters.
  • M&T Bank's MaxCyte position peaked at $726K in Q2 2023.
  • 115 funds tracked by Wall St. Rank held MaxCyte as of Q1 2025.

Based on M&T Bank's 13F filing for Q1 2025, filed 30 Apr 2025.